US PTAB IP Litigation
8,574 annotated decisions
Page 336 of 358 · 8,574 total
patent denied
Databricks, Inc. v.R2 Solutions LLC
· IPR2024-00659
Databricks, Inc. failed to overcome obviousness challenges against R2 Solutions LLC's patent (8190610) regarding MapReduce data grouping. The PTAB denied institution because Petitioner relied on speculative hindsight rather than demonstrating a clear motivation from prior art references like Pike and Chowdhuri.
patent instituted
Merck Sharp & Dohme LLC et al. v.The Johns Hopkins University
· IPR2024-00650
Merck Sharp & Dohme LLC successfully challenged The Johns Hopkins University's patent (11634491) in a PTAB Institution Decision. The Board found reasonable likelihood of success for multiple claims under both anticipation (§ 102) and obviousness (§ 103).
patent instituted
Merck Sharp & Dohme LLC et al. v.The Johns Hopkins University
· IPR2024-00649
Merck Sharp & Dohme LLC successfully challenged The Johns Hopkins University's patent claims regarding MSI-H cancer treatment, leading the PTAB to institute proceedings. The petitioner argued that the claimed methods were anticipated by or obvious over existing prior art, including the MSI-H Study Record and various medical literature.
patent instituted
Merck Sharp & Dohme LLC et al. v.The Johns Hopkins University
· IPR2024-00648
Merck Sharp & Dohme LLC successfully petitioned to institute IPR proceedings against The Johns Hopkins University regarding a patent on immunotherapy methods. The Board found reasonable likelihood of unpatentability under both 102 and 103, primarily based on the MSI-H Study Record.
patent instituted
Merck Sharp & Dohme LLC et al. v.The Johns Hopkins University
· IPR2024-00647
Merck Sharp & Dohme LLC successfully petitioned to institute IPR against The Johns Hopkins University regarding claims related to anti-PD-1 antibody treatment for MSI colorectal cancer. The Board found a reasonable likelihood of success under both 102 and 103 grounds across all 36 claims at issue.
patent instituted
Aptiv Services US, LLC et al. v.Microchip Technology, Inc.
· IPR2024-00646
Aptiv Services challenged Microchip Technology's patent (9471074) in an IPR, arguing obviousness over Al-Shyoukh in view of Ivanov and Stanescu. The PTAB institution decision granted the petition, proceeding to trial on 18 claims.
patent instituted
Loco Crazy Good Cookers, Inc. v.North Atlantic Imports, LLC
· IPR2024-00642
Loco Crazy Good Cookers challenged North Atlantic Imports' cooking appliance patent on grounds of obviousness and anticipation. The PTAB instituted review, finding a reasonable likelihood that at least one claim would be obvious based on the prior art references. This moves the dispute toward trial preparation in District Court.
patent denied
AT&T Corp et al. v.Daingean Technologies Ltd.
· IPR2024-00644
The PTAB denied institution of IPR against Daingean Technologies' patent, finding that the petitioner failed to prove its sole prior art reference (R2-1702708) was a publicly accessible printed publication.
patent instituted
Under Armour, Inc. v.Athalonz, LLC
· IPR2024-00639
Under Armour successfully petitioned the PTAB to institute IPR on claims related to athletic footwear sole technology, arguing they are obvious under 35 U.S.C. § 103. The Board granted institution, adopting key claim constructions and recognizing the validity of multiple prior art combinations cited by the Petitioner.
patent instituted
Under Armour, Inc. v.Athalonz, LLC
· IPR2024-00640
The PTAB granted institution of IPR for Under Armour against Athalonz regarding athletic footwear claims. The Board adopted key claim constructions and found a reasonable likelihood of obviousness over the prior art reference 'Won' for several independent claims.
patent instituted
Under Armour, Inc. v.Athalonz, LLC
· IPR2024-00638
Under Armour successfully petitioned to institute an IPR against Athalonz, LLC's shoe patent (11,064,760 B2). The Board found a reasonable likelihood of success on obviousness grounds over prior art like Kim and Dufour.
patent instituted
Under Armour, Inc. v.Athalonz, LLC
· IPR2024-00636
Under Armour successfully secured institution of IPR against Athalonz's shoe patent (10,674,786), challenging claims 1-8 based on obviousness over prior art like Kim and Dufour.
patent instituted
Under Armour, Inc. v.Athalonz, LLC
· IPR2024-00637
Under Armour successfully secured institution of IPR against Athalonz's patent (11,013,291) for athletic footwear. The Board found a reasonable likelihood that the claims are obvious over prior art reference Kim.
patent instituted
Fluidmaster, Inc. v.Danco, Inc. et al.
· IPR2024-00635
Fluidmaster successfully petitioned the PTAB against Danco, Inc., leading to the institution of trial on all 14 claims. The Board found sufficient evidence that the patent's features were obvious under 35 U.S.C. § 103 using various prior art references. This decision significantly advances Fluidmaster’s challenge in related district court litigation.
patent instituted
Fluidmaster, Inc. v.Danco, Inc. et al.
· IPR2024-00634
Fluidmaster successfully moved forward with its IPR challenge against Danco's patent (9103105) regarding toilet fill valves. The Board granted institution on multiple grounds, setting the stage for a full trial to determine if the claims are unpatentable over prior art combinations.
patent instituted
Fluidmaster, Inc. v.Danco, Inc. et al.
· IPR2024-00633
Fluidmaster successfully petitioned the PTAB to institute an IPR against Danco's patent, challenging 20 claims based on obviousness (35 U.S.C. § 103). The Board adopted a narrow claim construction for 'integrally molded with,' defining it as being formed as a single structure.
patent instituted
TESLA, INC. v.iQar Inc.
· IPR2024-00630
Tesla Inc.'s IPR against iQar Inc. was instituted by the PTAB, allowing claims related to vehicle power management logic to proceed to trial. The Board found a reasonable likelihood of prevailing on both anticipation (102) and obviousness (103), particularly regarding the combination of prior art references.
patent instituted
Amazon.com, Inc. et al. v.Nokia Technologies Oy
· IPR2024-00627
Amazon successfully navigated the institution phase of its IPR against Nokia regarding video coding claims. The Board found a reasonable likelihood that Amazon could prove unpatentability under § 103, leading to the case being instituted for trial.
patent instituted
Amazon.com, Inc. et al. v.Nokia Technologies Oy
· IPR2024-00626
Amazon successfully challenged Nokia's patent claims in an IPR proceeding regarding video coding and motion prediction technology. The Board found a reasonable likelihood of prevailing on the grounds of obviousness over prior art, leading to institution.
patent instituted
Merck Sharp & Dohme LLC et al. v.The Johns Hopkins University
· IPR2024-00625
Merck Sharp & Dohme LLC successfully petitioned to institute IPR proceedings against The Johns Hopkins University regarding anti-cancer immunotherapy claims. The Board found sufficient evidence that the MSI-H Study Record anticipates key claims, warranting further trial on grounds of anticipation and obviousness.
patent instituted
Merck Sharp & Dohme LLC et al. v.The Johns Hopkins University
· IPR2024-00624
Merck Sharp & Dohme LLC successfully instituted an IPR against The Johns Hopkins University's patent, challenging claims related to anti-PD-1 antibodies for MSI-high cancer. The Board found sufficient evidence that prior art anticipated and rendered the claims obvious, leading to a trial institution decision.
patent instituted
Merck Sharp & Dohme LLC et al. v.The Johns Hopkins University
· IPR2024-00623
Merck Sharp & Dohme LLC successfully secured institution for its IPR challenge against The Johns Hopkins University regarding oncology/immunotherapy claims. The Board found sufficient evidence to proceed under 35 U.S.C. § 102 and § 103, despite procedural challenges from the Patent Owner.
patent instituted
Merck Sharp & Dohme LLC et al. v.The Johns Hopkins University
· IPR2024-00622
Merck Sharp & Dohme LLC successfully convinced the PTAB to institute IPR proceedings against The Johns Hopkins University regarding anti-cancer therapies using PD-1 blockade. The Board found sufficient evidence that prior art, including the MSI-H Study Record, renders several claims unpatentable.
patent denied
Mito Red Light, Inc. v.Joovv, Inc.
· IPR2024-00621
Mito Red Light, Inc.'s challenge against Joovv, Inc.'s light therapy patent was denied by the PTAB. The Board found that Petitioner failed to establish unpatentability under § 103 using references Dijkstra and Norwood.
